Treatment reduced hospitalization risk by 72%, said CEO David Ricks

New coronavirus antibody treatment by Eli-Lilly reduces need for hospitalization: study

By Fox News —— Bio and Archives--September 16, 2020

News Headlines | Comments | Back To Full Article

A clinical trial assessing Eli Lilly’s experimental antibody treatment reduced the rate of hospitalization in COVID-19 patients, the pharmaceutical company's CEO David Ricks told FOX Business' Maria Bartiromo on Wednesday. “This is an important day in the fight against COVID,” Ricks said on “Mornings with Maria.”-- More...

Read Full Article...

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Commenting is not available in this channel entry.

Comments

Support Canada Free Press

Recommended by Canada Free Press